Last edited by Gardalkis
Wednesday, May 6, 2020 | History

4 edition of Mechanisms of progression to hormone-independent growth of breast and prostatic cancer found in the catalog.

Mechanisms of progression to hormone-independent growth of breast and prostatic cancer

  • 378 Want to read
  • 4 Currently reading

Published by Parthenon Pub. Group in Carnforth, Lancs, UK, Park Ridge, N.J., USA .
Written in English

    Subjects:
  • Prostate -- Cancer -- Endocrine aspects -- Congresses.,
  • Breast -- Cancer -- Endocrine aspects -- Congresses.,
  • Breast Neoplasms -- drug therapy -- congresses.,
  • Breast Neoplasms -- physiopathology -- congresses.,
  • Drug Resistance -- congresses.,
  • Hormones -- pharmacology -- congresses.,
  • Prostatic Neoplasms -- drug therapy -- congresses.,
  • Prostatic Neoplasms -- physiopathology -- congresses.

  • Edition Notes

    Statementedited by E.M.J.J. Berns, J.C. Romijn, and F.H. Schröder.
    ContributionsBerns, P. M. J. J., Romijn, J. C., Schröder, F. H.
    Classifications
    LC ClassificationsRC280.P7 M42 1991
    The Physical Object
    Paginationviii, 200 p. :
    Number of Pages200
    ID Numbers
    Open LibraryOL2027018M
    ISBN 101850703566
    LC Control Number91003010

    In vitro and in vivo model systems used in prostate cancer research New incidence of prostate cancer is a major public health issue in the Western world, and has been rising in . “The Role of the Akt Kinase Pathway in the Development of Hormone-Independent Breast Cancer”. Department of Medicine Research Conference. October “Using Fatty Acids for the Treatment of Hormone Resistant Breast Cancer”, University of Texas at Austin, Division of Nutrition, Department of Human Ecology, January,

    Prostate Cancer Prevention Controversy. By William Faloon. An editorial I generated for the May issue of Life Extension magazine® received quite a bit of feedback and critique.. Some Life Extension® customers said it should be a mandatory part of physician angelstouch16.com raised concerns about the use of the PSA blood test as a screening tool, why I suggest Avodart® for certain men. In metastatic prostate cancer, resistance to hormone therapy and the androgen-independent growth of cancer cells are considered key factors of patient survival because hormone therapy is the standard and main treatment in most of these patients. 6,34 In this study, we evaluated the polymorphisms of 13 genes previously reported to be associated Cited by:

    Prostate cancer will be diagnosed in more than , American men this year. About 26, will die from metastatic disease that originates in the prostate gland. 1. The prostate-specific antigen (PSA) blood test enables early detection that leads to higher cure rates. 2. Despite prostate cancer being the second leading cause of cancer mortality in American men, 1 there has been a raging Author: William Faloon. Abstract. Breast cancer (BC) is among the most prevalent type of malignancy affecting females worldwide. BC is classified into different types according to the status of the expression of receptors such as estrogen receptor (ER), human epidermal growth factor receptor 2 Author: Nihad Al-Othman, Ala’ Alhendi, Manal Ihbaisha, Myassar Barahmeh, Moath Alqaraleh, Bayan Z. Al-Momany.


Share this book
You might also like
The Maritime medical news

The Maritime medical news

pathway to peace

pathway to peace

Crystals and Minerals

Crystals and Minerals

Ghosts of the Golden West

Ghosts of the Golden West

History of the cattle industry in southern Arizona, 1540-1940.

History of the cattle industry in southern Arizona, 1540-1940.

Skill, technology, and enlightenment

Skill, technology, and enlightenment

New Irish architecture.

New Irish architecture.

Slough Properties Ltd, Utilities Services Division

Slough Properties Ltd, Utilities Services Division

Regulations 101, income tax

Regulations 101, income tax

The Dieters Companion--6-copy counter display

The Dieters Companion--6-copy counter display

William Henry Lewis.

William Henry Lewis.

Mechanisms of progression to hormone-independent growth of breast and prostatic cancer Download PDF EPUB FB2

Get this from a library. Mechanisms of progression to hormone-independent growth of breast and prostatic cancer. [P M J J Berns; J C Romijn; F H Schröder;]. These and other intracellular mechanisms involved in hormone-independent cell growth are described in detail by Feldman & Feldman ().

The previous perspectives of hormone-independent prostate cancer has focused on abnormalities within the cancer cells. But these cells do not grow in a angelstouch16.com by: Apr 28,  · Introduction.

Prostate cancer is the most commonly diagnosed and second leading cause of cancer-related deaths among men in North America [].Statistically, one in six men will develop some form of prostate cancer in their lifetime, and interestingly, almost 50% of men have tumors within their prostate upon angelstouch16.com by: Mechanisms of Progression to Hormone-Independent Growth of Breast and Prostatic Cancer by Berns, P.

J., Romijn, J. and a great selection of related. What are the side effects of hormone therapy for prostate cancer. and cancer growth through mechanisms that don't involve the androgen receptor (20 Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer.

Prostate Cancer and Prostatic Diseases ; 10(4) [PubMed Abstract]. Progression from hormone dependent to hormone independent growth in MCF-7 human breast cancer cells Article (PDF Available) in Proceedings of the National Academy of Sciences 86(10) Nutrition methods and dietary supplements have been studied for prostate cancer prevention or treatment.

Read about the history of research, laboratory, and human studies on various prostate supplements, such as calcium, green tea, lycopene, pomegranate, selenium, soy, and vitamin E in this expert-reviewed summary. Sep 01,  · Multiple mechanisms of resistance contribute to the inevitable progression of hormone-sensitive prostate cancer to castration-resistant prostate cancer (CRPC).

Currently approved therapies for CRPC include systemic chemotherapy (docetaxel and cabazitaxel) and agents targeting the resistance pathways leading to CRPC, including enzalutamide and abiraterone.

While there is significant survival Cited by: Len Neckers, in The Molecular Basis of Cancer (Third Edition), Hsp90 Inhibitors Target the Androgen Receptor in Prostate Cancer. Androgen receptor continues to be expressed in most hormone-independent prostate cancers, suggesting that it remains important for tumor growth and survival.

Receptor overexpression, mutation, and/or post-translational modification may all be mechanisms by. Mechanisms of resistance in castration-resistant prostate cancer (CRPC) Despite advances in prostate cancer diagnosis and management, morbidity from prostate cancer remains high.

Approximately 20% of men present with advanced or metastatic disease, while 29, men. Van Weerden WM () Animal models in the study of progression of prostate cancer and breast cancer to endocrine independency. In: Berns PMJJ, Romijn JC, Schröder FH (eds) Mechanisms of progression to hormone-independent growth of breast and prostatic cancer.

Parthenon, Carnforth, pp 55–70 Google ScholarAuthor: G. van Steenbrugge, W. van Weerden, M. Oomen, C. de Ridder, T. van der Kwast, F. It explores mechanisms of loss of endocrine control in experimental and clinical breast cancer, commonly observed following systemic therapy.

Loss of estrogenic control of breast cancer growth during malignant progression implies the existence of other growth control processes which take over in its angelstouch16.com by: Mechanisms of ARE-Independent Gene Activation by the Androgen Receptor in Prostate Cancer Cells: Potential Targets for Better Intervention Strategies for supporting growth through progression.

Background: Prostate cancer-associated fibroblasts (CAF) can stimulate malignant progression and invasion of prostatic tumour cells via several mechanisms including those active in extracellular matrix; Methods: We isolated CAF from prostate cancer patients of Gleason Score 6–10 and confirmed their cancer-promoting activity using an in vivo tumour reconstitution assay comprised of CAF and Cited by: 5.

Cancer has replaced heart disease as the leading cause of death in North America – nearly half will develop cancer, and one in four will die from the disease [1]. Prostate cancer (PCa) is the most Cited by: 1. Abstract. Breast cancer (BC) is the most frequent type of malignancy affecting females worldwide.

Molecular–based studies resulted in an identification of at least four subtypes of breast carcinoma, including luminal A and luminal B, Human growth factor receptor (HER-2)-enriched and triple-negative tumors (basal-like and normal breast-like).Cited by: 1.

Dec 03,  · In this article, the pathologic effects of hormonal therapy on benign prostatic tissue and prostate cancer are presented. Hormonal therapy is the main treatment for men with disseminated prostate cancer.

[] In addition, hormonal therapy, also known as endocrine- or androgen-deprivation therapy, is commonly used in locally advanced or high-grade, high-risk disease. Keywords:Fibroblast growth factor, mammary gland, breast cancer, prostate. Abstract: The fibroblast growth factor (FGF) family is comprised of 22 ligands that bind and activate several FGF receptor (FGFR) isoforms.

Critical roles for FGFs and FGFRs have been well-established during embryonic development. FGF has been shown to be associated with cancer progression in several experimental models.

For example, binding of FGF-2 to its receptor activates the progesterone receptor in mouse mammary tumor cells, thus promoting tumor proliferation ; in addition, FGF-2 stimulates proliferation of human breast cancer cells as well.

Prostate cancer (CaP) is the leading cause of cancer in men affecting 24, Canadians each year and the third leading cause of cancer mortality with 4, deaths each year.

CaP cells are derived from the prostate secretory epithelium and depend on androgen ligand activation of androgen receptor (AR) for survival, growth and angelstouch16.com by: 1. Nov 04,  · Although hormonal therapy is highly effective for the control of cancer-related symptoms, all men who live long enough will eventually experience disease progression and develop castration.For example Olaparib has proved to be very efficient in patients with breast or ovarian cancer with germline mutations in these two genes [].

Although mutations on BCRA2 mutations have a major impact on breast cancer growth, males carrying alteration on this gene also have a high risk of develop prostate cancer [, ]. Additional Author: Luis A. Espinoza.Furthermore, miR and miR contribute to the growth and maintenance of castration-resistant prostate cancer (CRPC) through mechanisms that comprise the AR signaling.

Another oncomir, miRb, was reported to be over-expressed in androgen-independent prostate cancer lines and was also implicated in the hormone independent angelstouch16.com: Geraldine Gueron, Javier Cotignola, Elba Vazquez.